Suppr超能文献

头颈部癌症中缺氧(18)F-氟莫司汀动态 PET 的药代动力学分析。

Pharmacokinetic analysis of hypoxia (18)F-fluoromisonidazole dynamic PET in head and neck cancer.

机构信息

Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

出版信息

J Nucl Med. 2010 Jan;51(1):37-45. doi: 10.2967/jnumed.109.067009. Epub 2009 Dec 15.

Abstract

UNLABELLED

This study used pharmacokinetic analysis of (18)F-labeled fluoromisonidazole ((18)F-FMISO) dynamic PET to assist the identification of regional tumor hypoxia and to investigate the relationship among a potential tumor hypoxia index (K(i)), tumor-to-blood ratio (T/B) in the late-time image, plasma-to-tissue transport rate (k(1)), and local vascular volume fraction (beta) for head and neck cancer patients.

METHODS

Newly diagnosed patients underwent a dynamic (18)F-FMISO PET scan before chemotherapy or radiotherapy. The data were acquired in 3 consecutive PET/CT dynamic scan segments, registered with each other and analyzed using pharmacokinetics software. The (K(i), k(1), beta) kinetic parameter images were derived for each patient.

RESULTS

Nine patients' data were analyzed. Representative images of (18)F-FDG PET (of the tumor), CT (of the anatomy), and late-time (18)F-FMISO PET (of the T/B) and parametric images of K(i) (potentially representing tumor hypoxia) are shown. The patient image data could be classified into 3 types: with good concordance between the parametric hypoxia map K(i) and high T/B, with concordant findings between the parametric hypoxia map and low T/B, and with ambiguity between parametric hypoxia map and T/B. Correlation coefficients are computed between each pair of T/B, K(i), k(1), and beta. Data are also presented for other potential hypoxia surrogate measures, for example, k(3) and k(1)/k(2).

CONCLUSION

There is a positive correlation of 0.86 between the average T/B and average hypoxia index K(i) of the region of interest. However, because of the statistical photon counting noise in PET and the amplification of noise in kinetic analysis, the direct correlation between the T/B and hypoxia of the individual pixel is not obvious. For a tumor region of interest, there is a slight negative correlation between k(1) and K(i), moderate positive correlation between beta and K(i), but no correlation between beta and k(1).

摘要

目的

本研究使用(18)F 标记氟米索硝唑((18)F-FMISO)动态 PET 的药代动力学分析来辅助识别局部肿瘤缺氧,并探讨潜在肿瘤缺氧指数(K(i))、晚期图像肿瘤与血液比(T/B)、血浆与组织转运率(k(1))和局部血管体积分数(β)之间的关系。

方法

新诊断的患者在化疗或放疗前进行动态(18)F-FMISO PET 扫描。数据在 3 个连续的 PET/CT 动态扫描段中采集,相互配准并使用药代动力学软件进行分析。为每位患者生成(K(i),k(1),β)动力学参数图像。

结果

分析了 9 名患者的数据。展示了(18)F-FDG PET(肿瘤)、CT(解剖结构)、晚期(18)F-FMISO PET(T/B)和 K(i)(潜在代表肿瘤缺氧)参数图像的代表性图像。患者图像数据可分为 3 种类型:参数缺氧图 K(i)与高 T/B 之间有很好的一致性,参数缺氧图与低 T/B 之间有一致性,参数缺氧图与 T/B 之间有模糊性。计算了 T/B、K(i)、k(1)和β之间的每对相关系数。还提供了其他潜在缺氧替代指标的数据,例如 k(3)和 k(1)/k(2)。

结论

感兴趣区域的平均 T/B 与平均缺氧指数 K(i)之间存在 0.86 的正相关。然而,由于 PET 中的统计光子计数噪声和动力学分析中噪声的放大,个体像素的 T/B 与缺氧之间的直接相关性不明显。对于肿瘤感兴趣区域,k(1)与 K(i)之间存在轻微负相关,β与 K(i)之间存在中度正相关,但β与 k(1)之间无相关性。

相似文献

1
Pharmacokinetic analysis of hypoxia (18)F-fluoromisonidazole dynamic PET in head and neck cancer.
J Nucl Med. 2010 Jan;51(1):37-45. doi: 10.2967/jnumed.109.067009. Epub 2009 Dec 15.
2
Multiparametric Imaging of Tumor Hypoxia and Perfusion with F-Fluoromisonidazole Dynamic PET in Head and Neck Cancer.
J Nucl Med. 2017 Jul;58(7):1072-1080. doi: 10.2967/jnumed.116.188649. Epub 2017 Feb 9.
3
High reproducibility of tumor hypoxia evaluated by 18F-fluoromisonidazole PET for head and neck cancer.
J Nucl Med. 2013 Feb;54(2):201-7. doi: 10.2967/jnumed.112.109330. Epub 2013 Jan 15.
4
Monitoring early response to chemoradiotherapy with F-FMISO dynamic PET in head and neck cancer.
Eur J Nucl Med Mol Imaging. 2017 Sep;44(10):1682-1691. doi: 10.1007/s00259-017-3720-6. Epub 2017 May 24.
7
Reproducibility of intratumor distribution of (18)F-fluoromisonidazole in head and neck cancer.
Int J Radiat Oncol Biol Phys. 2008 Jan 1;70(1):235-42. doi: 10.1016/j.ijrobp.2007.08.036.
8
Pharmacokinetic Analysis of Dynamic F-Fluoromisonidazole PET Data in Non-Small Cell Lung Cancer.
J Nucl Med. 2017 Jun;58(6):911-919. doi: 10.2967/jnumed.116.180422. Epub 2017 Feb 23.
9
Feasibility of 18F-Fluoromisonidazole Kinetic Modeling in Head and Neck Cancer Using Shortened Acquisition Times.
J Nucl Med. 2016 Mar;57(3):334-41. doi: 10.2967/jnumed.115.160168. Epub 2015 Nov 25.

引用本文的文献

2
Kinetic Evaluation of the Hypoxia Radiotracers [F]FMISO and [F]FAZA in Dogs with Spontaneous Tumors Using Dynamic PET/CT Imaging.
Nucl Med Mol Imaging. 2023 Feb;57(1):16-25. doi: 10.1007/s13139-022-00780-4. Epub 2022 Oct 11.
3
Bioimaging guided pharmaceutical evaluations of nanomedicines for clinical translations.
J Nanobiotechnology. 2022 May 19;20(1):236. doi: 10.1186/s12951-022-01451-4.
4
Prospective Evaluation of a Tumor Control Probability Model Based on Dynamic F-FMISO PET for Head and Neck Cancer Radiotherapy.
J Nucl Med. 2019 Dec;60(12):1698-1704. doi: 10.2967/jnumed.119.227744. Epub 2019 May 10.
5
Towards clinically translatable nanodiagnostics.
Nat Rev Mater. 2017 May;2(5). doi: 10.1038/natrevmats.2017.14. Epub 2017 May 3.
6
Impact of tissue transport on PET hypoxia quantification in pancreatic tumours.
EJNMMI Res. 2017 Dec 22;7(1):101. doi: 10.1186/s13550-017-0347-3.
7
F-fluoromisonidazole uptake in advanced stage non-small cell lung cancer: A voxel-by-voxel PET kinetics study.
Med Phys. 2017 Sep;44(9):4665-4676. doi: 10.1002/mp.12416. Epub 2017 Jul 21.
8
Hypoxia imaging and radiotherapy: bridging the resolution gap.
Br J Radiol. 2017 Aug;90(1076):20160939. doi: 10.1259/bjr.20160939. Epub 2017 May 25.
9
Pharmacokinetic Analysis of Dynamic F-Fluoromisonidazole PET Data in Non-Small Cell Lung Cancer.
J Nucl Med. 2017 Jun;58(6):911-919. doi: 10.2967/jnumed.116.180422. Epub 2017 Feb 23.
10
Pharmacokinetic modeling of a novel hypoxia PET tracer [F]HX4 in patients with non-small cell lung cancer.
EJNMMI Phys. 2016 Dec;3(1):30. doi: 10.1186/s40658-016-0167-y. Epub 2016 Dec 12.

本文引用的文献

1
Evaluation of a compartmental model for estimating tumor hypoxia via FMISO dynamic PET imaging.
Phys Med Biol. 2009 May 21;54(10):3083-99. doi: 10.1088/0031-9155/54/10/008. Epub 2009 May 6.
3
Hypoxia-imaging with (18)F-Misonidazole and PET: changes of kinetics during radiotherapy of head-and-neck cancer.
Radiother Oncol. 2007 Jun;83(3):406-10. doi: 10.1016/j.radonc.2007.05.014. Epub 2007 May 31.
4
Tumor hypoxia imaging with [F-18] fluoromisonidazole positron emission tomography in head and neck cancer.
Clin Cancer Res. 2006 Sep 15;12(18):5435-41. doi: 10.1158/1078-0432.CCR-05-1773.
6
Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study.
Radiother Oncol. 2005 Oct;77(1):18-24. doi: 10.1016/j.radonc.2005.06.038. Epub 2005 Aug 10.
7
A kinetic model for dynamic [18F]-Fmiso PET data to analyse tumour hypoxia.
Phys Med Biol. 2005 May 21;50(10):2209-24. doi: 10.1088/0031-9155/50/10/002. Epub 2005 Apr 27.
8
The impact of daily setup variations on head-and-neck intensity-modulated radiation therapy.
Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):779-88. doi: 10.1016/j.ijrobp.2004.07.696.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验